Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol Res ; 2015: 738020, 2015.
Article in English | MEDLINE | ID: mdl-26605344

ABSTRACT

Concerns that variola viruses might be used as bioweapons have renewed the interest in developing new and safer smallpox vaccines. Variola virus genomes are now widely available, allowing computational characterization of the entire T-cell epitome and the use of such information to develop safe and yet effective vaccines. To this end, we identified 124 proteins shared between various species of pathogenic orthopoxviruses including variola minor and major, monkeypox, cowpox, and vaccinia viruses, and we targeted them for T-cell epitope prediction. We recognized 8,106, and 8,483 unique class I and class II MHC-restricted T-cell epitopes that are shared by all mentioned orthopoxviruses. Subsequently, we developed an immunological resource, EPIPOX, upon the predicted T-cell epitome. EPIPOX is freely available online and it has been designed to facilitate reverse vaccinology. Thus, EPIPOX includes key epitope-focused protein annotations: time point expression, presence of leader and transmembrane signals, and known location on outer membrane structures of the infective viruses. These features can be used to select specific T-cell epitopes suitable for experimental validation restricted by single MHC alleles, as combinations thereof, or by MHC supertypes.


Subject(s)
Antigens, Viral/immunology , Computational Biology/methods , Epitopes, T-Lymphocyte/immunology , Orthopoxvirus/immunology , Software , T-Lymphocytes/immunology , Variola virus/immunology , Amino Acid Sequence , Antigens, Viral/chemistry , Cross-Priming/immunology , Databases, Protein , Epitopes, T-Lymphocyte/chemistry , Humans , Viral Vaccines/immunology , Web Browser
2.
Bioinformatics ; 21(9): 2140-1, 2005 May 01.
Article in English | MEDLINE | ID: mdl-15657103

ABSTRACT

SUMMARY: EPIMHC is a relational database of MHC-binding peptides and T cell epitopes that are observed in real proteins. Currently, the database contains 4867 distinct peptide sequences from various sources, including 84 tumor-associated antigens. The EPIMHC database is accessible through a web server that has been designed to facilitate research in computational vaccinology. Importantly, peptides resulting from a query can be selected to derive specific motif-matrices. Subsequently, these motif-matrices can be used in combination with a dynamic algorithm for predicting MHC-binding peptides from user-provided protein queries. AVAILABILITY: The EPIMHC database server is hosted by the Dana-Farber Cancer Institute at the site http://immunax.dfci.harvard.edu/bioinformatics/epimhc/


Subject(s)
Database Management Systems , Databases, Protein , Histocompatibility Antigens/chemistry , Major Histocompatibility Complex , Peptides/chemistry , Sequence Analysis, Protein/methods , User-Computer Interface , Vaccination , Drug Design , Epitope Mapping/methods , HLA Antigens/chemistry , Information Storage and Retrieval/methods , Protein Binding , Software
3.
Immunogenetics ; 56(6): 405-19, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15349703

ABSTRACT

We introduced previously an on-line resource, RANKPEP that uses position specific scoring matrices (PSSMs) or profiles for the prediction of peptide-MHC class I (MHCI) binding as a basis for CD8 T-cell epitope identification. Here, using PSSMs that are structurally consistent with the binding mode of MHC class II (MHCII) ligands, we have extended RANKPEP to prediction of peptide-MHCII binding and anticipation of CD4 T-cell epitopes. Currently, 88 and 50 different MHCI and MHCII molecules, respectively, can be targeted for peptide binding predictions in RANKPEP. Because appropriate processing of antigenic peptides must occur prior to major histocompatibility complex (MHC) binding, cleavage site prediction methods are important adjuncts for T-cell epitope discovery. Given that the C-terminus of most MHCI-restricted epitopes results from proteasomal cleavage, we have modeled the cleavage site from known MHCI-restricted epitopes using statistical language models. The RANKPEP server now determines whether the C-terminus of any predicted MHCI ligand may result from such proteasomal cleavage. Also implemented is a variability masking function. This feature focuses prediction on conserved rather than highly variable protein segments encoded by infectious genomes, thereby offering identification of invariant T-cell epitopes to thwart mutation as an immune evasion mechanism.


Subject(s)
Epitopes, T-Lymphocyte/metabolism , Histocompatibility Antigens Class II/metabolism , Histocompatibility Antigens Class I/metabolism , Peptide Fragments/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/physiology , Algorithms , Amino Acid Motifs , Antigen Presentation , Histocompatibility Antigens Class I/chemistry , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class II/chemistry , Histocompatibility Antigens Class II/genetics , Humans , Models, Molecular , Peptide Fragments/chemistry , Peptide Fragments/genetics
4.
Hum Immunol ; 63(9): 701-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12175724

ABSTRACT

Peptides that bind to a given major histocompatibility complex (MHC) molecule share sequence similarity. Therefore, a position specific scoring matrix (PSSM) or profile derived from a set of peptides known to bind to a specific MHC molecule would be a suitable predictor of whether other peptides might bind, thus anticipating possible T-cell epitopes within a protein. In this approach, the binding potential of any peptide sequence (query) to a given MHC molecule is linked to its similarity to a group of aligned peptides known to bind to that MHC, and can be obtained by comparing the query to the PSSM. This article describes the derivation of alignments and profiles from a collection of peptides known to bind a specific MHC, compatible with the structural and molecular basis of the peptide-MHC class I (MHCI) interaction. Moreover, in order to apply these profiles to the prediction of peptide-MHCI binding, we have developed a new search algorithm (RANKPEP) that ranks all possible peptides from an input protein using the PSSM coefficients. The predictive power of the method was evaluated by running RANKPEP on proteins known to bear MHCI K(b)- and D(b)-restricted T-cell epitopes. Analysis of the results indicates that > 80% of these epitopes are among the top 2% of scoring peptides. Prediction of peptide-MHC binding using a variety of MHCI-specific PSSMs is available on line at our RANKPEP web server (www.mifoundation.org/Tools/rankpep.html). In addition, the RANKPEP server also allows the user to enter additional profiles, making the server a powerful and versatile computational biology benchmark for the prediction of peptide-MHC binding.


Subject(s)
Carrier Proteins/metabolism , Histocompatibility Antigens Class I/metabolism , Algorithms , Amino Acid Motifs , Amino Acid Sequence , Animals , Antigen Presentation , Carrier Proteins/chemistry , Carrier Proteins/genetics , Epitopes/metabolism , Humans , Mice , Models, Molecular , Peptides/chemistry , Peptides/genetics , Peptides/metabolism , Protein Conformation , T-Lymphocytes, Cytotoxic/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...